Entasis Therapeutics Holdings Inc. ETTX

Set alert

Price alert · ETTX

All alert types
2.19 +2.19 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Aug 10, 2022
50-d avg
0.00
200-d avg
0.00
1y target
2.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ETTX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 2.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ETTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.29-0.32 – -0.28-0.290.0%00.0%3
Next quarter-0.30-0.38 – -0.24-0.26-15.4%00.0%3
Current year-1.20-1.31 – -1.08-1.09-10.1%00.0%3
Next year-1.15-1.24 – -1.06-1.20+4.2%10.67M0.0%2

Upgrades and downgrades

The latest rating changes

ETTX analyst upgrades and downgrades
DateFirmActionFromTo
May 5, 2022Cantor FitzgeraldDowngradeOverweightNeutral
Mar 15, 2022Alliance Global PartnersDowngradeBuyNeutral
Mar 7, 2022WedbushDowngradeOutperformNeutral
Mar 3, 2022HC Wainwright & Co.DowngradeBuyNeutral
Oct 19, 2021BMO CapitalMaintained—Outperform
Oct 18, 2021HC Wainwright & Co.Maintained—Buy
Sep 8, 2020Cantor FitzgeraldInitiated—Overweight
Jul 12, 2020Roth CapitalInitiated—Buy
Apr 13, 2020H.C. WainwrightMaintained—Buy
Mar 11, 2020Credit SuisseMaintained—Outperform
Aug 18, 2019H.C. WainwrightInitiated—Buy
Oct 23, 2018SunTrust Robinson HumphreyInitiated—Buy
Oct 21, 2018WedbushInitiated—Outperform
Oct 21, 2018BMO CapitalInitiated—Outperform